We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CECO icon
7276
PUT
Ceco Environmental
CECO
$3.92B
$98K ﹤0.01%
+19,200
New +$129K
NCZ
7277
Virtus Convertible & Income Fund II
NCZ
$296M
$98K ﹤0.01%
+3,946
New +$97.9K
NVAX icon
7278
CALL
Novavax
NVAX
$1.23B
$98K ﹤0.01%
3,960
-1,150
-23% -$28.1K
RCKT icon
7279
Rocket Pharmaceuticals
RCKT
$365M
$98K ﹤0.01%
9,416
+5,368
+133% +$53.2K
RMTI icon
7280
PUT
Rockwell Medical
RMTI
$29.4M
$98K ﹤0.01%
153
-27
-15% -$19K
CCLP
7281
DELISTED
CSI Compressco LP
CCLP
$98K ﹤0.01%
+17,893
New +$93.1K
OTIC
7282
CALL
DELISTED
Otonomy, Inc.
OTIC
$98K ﹤0.01%
17,600
+5,400
+44% +$23.4K
MXWL
7283
DELISTED
Maxwell Technologies Inc
MXWL
$98K ﹤0.01%
17,034
-17,729
-51% -$92.2K
JASO
7284
CALL
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$98K ﹤0.01%
13,100
-17,500
-57% -$130K
AOD
7285
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$96K ﹤0.01%
+10,087
New +$92K
CLIR icon
7286
ClearSign Technologies
CLIR
$26.7M
$95K ﹤0.01%
+2,640
New +$86.2K
IAF
7287
abrdn Australia Equity Fund
IAF
$123M
$95K ﹤0.01%
+4,993
New +$94.3K
LPG icon
7288
Dorian LPG
LPG
$1.99B
$95K ﹤0.01%
+11,594
New +$89.1K
AVEO
7289
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$95K ﹤0.01%
3,390
-2,410
-42% -$74.8K
ENIC icon
7290
Enel Chile
ENIC
$6.11B
$94K ﹤0.01%
16,477
-7,796
-32% -$44.5K
TLPH icon
7291
PUT
Talphera
TLPH
$68M
$94K ﹤0.01%
2,310
+5
+0.2% +$244
VEON icon
7292
CALL
VEON
VEON
$3.7B
$94K ﹤0.01%
976
+212
+28% +$20.7K
GSUM
7293
DELISTED
Gridsum Holding Inc.
GSUM
$94K ﹤0.01%
+10,282
New +$91.5K
AMSC icon
7294
American Superconductor
AMSC
$1.47B
$92K ﹤0.01%
+25,418
New +$97K
BBVA icon
7295
Banco Bilbao Vizcaya Argentaria
BBVA
$155B
$92K ﹤0.01%
+10,837
New +$92.3K
NNA
7296
DELISTED
Navios Maritime Acquisition Corporation
NNA
$92K ﹤0.01%
+5,521
New +$104K
AEG icon
7297
CALL
Aegon
AEG
$14B
$91K ﹤0.01%
+17,707
New +$86.3K
IGR
7298
CBRE Global Real Estate Income Fund
IGR
$710M
$91K ﹤0.01%
+11,527
New +$90.2K
DRRX
7299
DELISTED
DURECT Corp
DRRX
$90K ﹤0.01%
9,840
+5,971
+154% +$71K
FLNT
7300
PUT
Fluent
FLNT
$103M
$90K ﹤0.01%
3,417
-50
-1% -$1.33K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.